Medicilon's chemistry department consists of synthetic chemistry services and medicinal chemistry services. Clients can cooperate with us on an Fee for Service or Full Time Equivalent basis.
Ringene Biopharma's pan-FGFR1-4 irreversible inhibitor RG002 tablets was approved for clinical use with the help of Medicilon one-stop preclinical biopharmaceutical R&D service platform
Drug discovery is the initial stage of drug research and development. Through early research, the genetic functions and targets of target diseases are selected and confirmed, the lead compounds are screened and optimized, and the druggability studies such as early safety screening and drug modification are carried out to obtain druggability candidate compounds.
Medicilon’s drug discovery service is divided into two departments: Chemistry and Biology, with chemical and biological laboratories, equipped with SFC, Biacore 8K. #drugdiscovery
As a biology and medicine research enthusiast, I have a strong interest in exploring various aspects of biology and medical science.